Leading biopharma to unify global regulatory
operations on a single platform to speed submissions for new
patient therapies
BARCELONA, Spain, Feb. 4, 2025
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that
Servier will adopt Veeva RIM to unify its global regulatory
operations. By bringing regulatory processes together on a single
platform, Servier can improve visibility, submission speed, and
compliance.
"Unifying regulatory data, documents, and processes on Veeva RIM
will help Servier streamline operations and accelerate patient
access to new medicines," said Alexandra
Pearce, global head, worldwide regulatory affairs at
Servier. "With Veeva, we have a reliable partner to help us scale
and connect teams while driving better regulatory oversight and
reducing time to submission."
With headquarters in France,
Servier is an independent, global pharmaceutical leader in
delivering cardio-metabolism, venous diseases, and oncology
therapies. Veeva RIM is a unified platform of regulatory
applications, including Veeva Registrations, Veeva Submissions,
Veeva Submissions Publishing, and Veeva Submissions Archive,
offering biopharmas like Servier real-time visibility throughout
the regulatory process. With Veeva RIM, Servier has a solution that
enables quick adaptation to evolving EU regulatory demands. Veeva
is partnering with Servier to roll out the technology across
Europe, and globally, streamlining
regulatory operations to reduce time to market for new
therapies.
"Servier is showing true digital leadership in its approach to
transforming its regulatory operations," said Paul Attridge, vice president of Veeva RIM
strategy at Veeva Europe. "With our successful track record
implementing Veeva RIM, Veeva's French and global teams look
forward to helping Servier advance its regulatory management and
deliver medicines to patients more quickly."
Veeva RIM is part of Veeva Development Cloud, the
technology foundation for product development across clinical,
regulatory, quality, and safety.
Additional Information
For more on Veeva RIM, visit:
veeva.com/eu/VeevaRIM
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's
products and services and the expected results or benefits from use
of our products and services. These statements are based on our
current expectations. Actual results could differ materially from
those provided in this release and we have no obligation to update
such statements. There are numerous risks that have the potential
to negatively impact our results, including the risks and
uncertainties disclosed in our filing on Form 10-Q for the period
ended July 31, 2024, which you can
find here (a summary of risks which may impact our
business can be found on pages 36 and 37), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/servier-to-adopt-veeva-rim-to-streamline-and-advance-its-global-regulatory-operations-302366729.html
